GemVax&KAEL Co.,Ltd. (KOSDAQ:082270)
South Korea · Delayed Price · Currency is KRW 46,350
-4,350 (-8.58%)
Oct 10, 2025, 3:30 PM KST
GemVax&KAEL Revenue
GemVax&KAEL had revenue of 25.02B KRW in the quarter ending June 30, 2025, with 47.57% growth. This brings the company's revenue in the last twelve months to 68.40B, up 7.58% year-over-year. In the year 2024, GemVax&KAEL had annual revenue of 62.69B, down -13.18%.
Revenue (ttm)
68.40B
Revenue Growth
+7.58%
P/S Ratio
28.51
Revenue / Employee
375.81M
Employees
182
Market Cap
1,950.23B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 62.69B | -9.52B | -13.18% |
| Dec 31, 2023 | 72.21B | -3.60B | -4.74% |
| Dec 31, 2022 | 75.80B | 15.43B | 25.56% |
| Dec 31, 2021 | 60.37B | -5.29B | -8.06% |
| Dec 31, 2020 | 65.66B | 23.00B | 53.91% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.59T |
| SK hynix | 77.21T |
| LG Energy Solution | 25.16T |
| Samsung Biologics | 5,031.69B |
| Hanwha Aerospace | 19.25T |
| Hyundai Motor Company | 182.25T |
| HD Hyundai Heavy Industries | 15.58T |
| KB Financial Group | 14.92T |